Evidence map›Paper›PMID 34473505›Full record

ArticleJournal of proteome research2021

Column-based Technology for CD9-HPLC Immunoaffinity Isolation of Serum Extracellular Vesicles.

Jianhui Zhu, Jie Zhang, Xiaohui Ji, Zhijing Tan, David M Lubman

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Exosome enrichment from human serum using polyethylene glycol precipitation.Journal of analytical science and technology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jianhui ZhuDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-0051-7777
Jie ZhangDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-1395-4853
Xiaohui JiDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States.
Zhijing TanDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States.
David M LubmanDepartment of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-7731-0232
University of Michigan · USChongqing University · CN

Funding

Supplemental for Detection of Glycopeptides of MCI in Patient SerumR01CA160254 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David M. Lubman · 2012 to 2026
$5.4M
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec AssayR21CA189775 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUBMAN, DAVID M. · 2015 to 2016
$371k
Discovery and Validation of Biomarkers for Early Cancer Detection Using Mass SpectrometryR50CA221808 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZHU, JIANHUI · 2018 to 2020
$189k
NCI NIH HHS R01 CA160254NCI NIH HHS R21 CA189775NCI NIH HHS R50 CA221808
6 · The paper itself

Abstract

Serum-derived extracellular vesicles (EVs) are a promising source of biomarkers; however, major challenges in EV separation and proteomic profiling remain for isolating EVs from a small amount, that is, on the microliter scale, of human serum while minimizing the contamination of blood proteins and lipoprotein particles coeluting in EV preparations. Herein we have developed a column-based CD9-antibody-immobilized high-performance liquid chromatography immunoaffinity chromatography(CD9-HPLC-IAC) technology for EV isolation from a microliter scale of serum for downstream proteomic analysis. The CD9-HPLC-IAC method achieved EV isolation from 40 μL of serum in 30 min with a yield of 8.0 × 10

Indexed as

Extracellular VesiclesProteomicsBlood ProteinsChromatography, High Pressure LiquidHumansTechnologyTetraspanin 29Blood ProteinsCD9 protein, humanTetraspanin 29CD9extracellular vesiclesHPLCimmunoaffinity isolationproteomicsserum

Identifiers

PMID34473505
PMCPMC8496948
OpenAlexW3197672348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.